Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares Ultra QQQ ETF (QLD) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

ProShares Ultra QQQ ETFTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

ProShares Ultra QQQ ETF vs DENTSPLY SIRONA Inc — how do they compare? ProShares Ultra QQQ ETF trades at $98.58 (market cap $15.38B), while DENTSPLY SIRONA Inc trades at $8.86 (market cap $1.73B). The key difference: ProShares Ultra QQQ ETF is far larger — about 8.9× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while ProShares Ultra QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold ProShares Ultra QQQ ETF for 36 Days and DENTSPLY SIRONA Inc for 72 Days on average.

QLDXRAY
Market Cap
$15.38B$1.73B
Volume
4,844,0856,198,582
Sector
Leveraged / InverseHealth
52-Week High
$100.77$14.68
52-Week Low
$57.16$8.52
Typical Hold Time
36 Days72 Days
Enterprise Value
—$3.80B
Dividend Yield
—5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ProShares Ultra QQQ ETF

QLD, the ProShares Ultra QQQ ETF, trades at $98.43, down 1.8% on the day, with a bullish technical signal driven by moving averages. The ETF aims to deliver twice the daily return of the Nasdaq-100 Index. Recent news highlights its resilience compared to higher-leverage counterparts during market downturns, with institutional buying noted in Q2 2026.

The outlook hinges on Nasdaq-100 performance and Federal Reserve policy, with support at $96 and resistance at $100. Risks include market volatility and leverage decay. Analyst sentiment is mixed, advising caution until technical confirmation above key moving averages.

DENTSPLY SIRONA Inc

Dentsply Sirona (XRAY) trades at $8.73, near its 52-week low, with a bearish technical signal and negative profitability metrics. The company reported a Q2 2026 earnings beat but faces declining revenue and negative net income margins. Recent news highlights institutional stake increases and ongoing restructuring efforts amid a challenging dental market environment.

The outlook remains cautious due to persistent margin pressure and sales declines, though the consensus price target of $13.40 suggests potential upside. Key risks include competitive pressures and execution of the turnaround plan, while institutional buying indicates some long-term confidence.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QLD
75% Buy25% Sell
Avg holding period · 36 Days
XRAY

No sentiment data available yet.

About ProShares Ultra QQQ ETF

QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.

Read more on QLD →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →